Published in:

Open Access 01-12-2010 | Oral presentation

The SENSE trial: etravirine shows lower prevalence and severity of neuropsychiatric adverse events compared to efavirenz in treatment-naïve patients

Authors: HJ Stellbrink, S Rugina, C Zagler, S Esser, A Castagna, B Gazzard, A Hill, Y van Delft, S Marks

Published in: Journal of the International AIDS Society | Special Issue 4/2010